Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Delirium × suvorexant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 2 Delirium 1 Breast Neoplasms 1

Interventions

Saline Solution 3 Sodium Chloride 2 Dexmedetomidine 2 suvorexant 1 remimazolam 1 flurbiprofen axetil 1 dexamethasone 21-phosphate 1 Standard of Care 1 Propofol 1 Practice Guidelines as Topic 1 Interviews as Topic 1 Ibuprofen 1 Dexamethasone 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡